Jerome Stevens Pharmaceuticals, Inc., manufacturer of Unithroid©, the first FDA-approved Levothyroxine Sodium, USP therapy, announced today that it has ample supply to combat the announced shortage of Levoxyl©.
Read MoreJerome Stevens Pharmaceuticals, Inc., manufacturer of Unithroid©, the first FDA-approved Levothyroxine Sodium, USP therapy, announced today that it has ample supply to combat the announced shortage of Levoxyl©.
Read More